APA (7th ed.) Citation

Sebastian, M., & Thomas, M. (2019). A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. Cancer immunology immunotherapy, 68(5), . https://doi.org/10.1007/s00262-019-02315-x

Chicago Style (17th ed.) Citation

Sebastian, Martin, and Michael Thomas. "A Phase I/IIa Study of the MRNA-based Cancer Immunotherapy CV9201 in Patients with Stage IIIB/IV Non-small Cell Lung Cancer." Cancer Immunology Immunotherapy 68, no. 5 (2019). https://doi.org/10.1007/s00262-019-02315-x.

MLA (9th ed.) Citation

Sebastian, Martin, and Michael Thomas. "A Phase I/IIa Study of the MRNA-based Cancer Immunotherapy CV9201 in Patients with Stage IIIB/IV Non-small Cell Lung Cancer." Cancer Immunology Immunotherapy, vol. 68, no. 5, 2019, https://doi.org/10.1007/s00262-019-02315-x.